NCT03748940View on ClinicalTrials.gov

Study of LY3074828 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

June 18, 2019

Study Completion Date

June 18, 2019

Conditions
Healthy
Interventions
DRUG

LY3074828

Administered SC

DRUG

Placebo

Administered SC

DRUG

LY900021

Administered SC

Trial Locations (1)

LS2 9LH

Covance Clinical Research Ltd, Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03748940 - Study of LY3074828 in Healthy Participants | Biotech Hunter | Biotech Hunter